Shareholders Will Most Likely Find Revolution Medicines, Inc.'s (NASDAQ:RVMD) CEO Compensation Acceptable

By Yahoo! Finance | Jun 14, 2024 at 08:16 AM EST

Revolution Medicines' stock has grown 17% in the past three years, but EPS fell by 19%. Shareholders may address concerns at the upcoming AGM on CEO compensation. The CEO's pay aligns with industry standards, but company performance must improve to justify further raises.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.